CompaniesByCap
PMD
Psychemedics Corporation (PMD)
NASDAQ · Healthcare

Psychemedics Corporation Revenue 2020–2024

Psychemedics Corporation annual/quarterly revenue history and growth rate from 2020 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • Psychemedics Corporation revenue for the quarter ending December 31, 2024 was 4.4 M, a 11.46% decrease year-over-year.
  • Psychemedics Corporation revenue for the twelve months ending December 31, 2024 was 19.7 M.
  • Psychemedics Corporation annual revenue for 2024 was 19.7 M, a 10.92% decrease from 2023.
  • Psychemedics Corporation annual revenue for 2023 was 22.1 M, a 12.45% decrease from 2022.
  • Psychemedics Corporation annual revenue for 2022 was 25.2 M, a 1.33% increase from 2021.
  • Psychemedics Corporation annual revenue for 2021 was 24.9 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

Psychemedics Corporation (PMD) — Frequently Asked Questions

Psychemedics Corporation (PMD) is a publicly traded US company. It has a market capitalization of $12M. In fiscal 2020 it reported revenue of $21M and net income of -$4M. Explore PMD's stock price, financial statements, earnings history, margins and key ratios below.

What is Psychemedics Corporation's market cap?

Psychemedics Corporation (PMD) has a market capitalization of $12M.

What is the PMD stock price?

PMD trades at $2.21.

How much revenue does Psychemedics Corporation make?

Psychemedics Corporation reported revenue of $21M in fiscal 2020.

Is PMD profitable?

In fiscal 2020, Psychemedics Corporation reported net income of -$4M.